Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
about
Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.Use of adjuvants for immunotherapy.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.
P2860
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
@en
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
@nl
type
label
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
@en
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
@nl
prefLabel
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
@en
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
@nl
P2093
P2860
P50
P1476
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
@en
P2093
Franco M Buonaguro
Luisa Circelli
Regina Heidenreich
P2860
P2888
P304
P356
10.1007/S00262-016-1923-5
P577
2016-11-10T00:00:00Z